Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis

Journal: Science Translational Medicine

Published: 2019-10-23

DOI: 10.1126/scitranslmed.aax2945

Affiliations: 4

Authors: 11

Go to article
Institutions Share
Oxford University Hospitals NHS Trust (OUH), United Kingdom (UK) 0.41
NIHR Oxford Biomedical Research Centre (OxBRC), United Kingdom (UK) 0.36
AnaptysBio, Inc., United States of America (USA) 0.18
Intercollegiate Faculty of Biotechnology UG-MUG, Poland 0.05

Return